
China’s Jiangsu Hengrui Pharmaceuticals aims to raise up to $1.27 billion in Hong Kong IPO
Audio By Carbonatix (Reuters) -Chinese drug developer and producer Jiangsu Hengrui Pharmaceuticals is seeking to raise up to HK$9.89 billion ($1.27 billion) in a Hong Kong initial public offering, according to a regulatory filing made on Thursday. The …